Richter’s Uterine Fibroid Drug Esmya Hit By Liver Safety Concerns In EU

 
• By Ian Schofield
Side effects
Richter's Esmya is under scrutiny over reports of liver damage in the EU

More from Drug Safety

More from Pink Sheet